Israeli medical device company Inspira Technologies has announced the expansion of its HYLA blood sensor technology (HYLA) into a personalised Blood Lab Test offering.
The expansion aims to provide real-time patient blood work for the rapid detection of a life-threatening medical condition and its potential underlying development, within minutes.
Inspira said the HYLA business model is designed to replace the need for nurses to collect intermittent physical blood samples from patients through extracorporeal procedures.
It provides pre-determined setup options for the patient’s blood work and supports physical immediate intermittent blood work testing and analysis, said the medical device maker.
Inspira Technologies CEO Dagi Ben-Noon said: “Our plans to use HYLA to perform blood work without the need to take physical blood samples is part of a broader business strategy.
“The core technologies of the INSPIRA ART are progressing, with the Company currently performing a clinical evaluation of the HYLA blood technology at Sheba hospital, with results expected to be revealed in the near future.”
HYLA is intended to be used in ERs, ICUs, medical units and in operating rooms.
It can replace expensive equipment, eliminate the need for blood cartridges and dependency on central labs and reduce the burden on hospital staff.
HYLA can reduce countless tests performed each year, which between the time of ordering a blood test and when test results are received, impact patient treatment and outcomes.
The technology is currently being evaluated in patients undergoing open-heart procedures at Sheba Hospital.
Also, the company is preparing for a regulatory submission of the first configuration of the HYLA to the US Food and Drug Administration (FDA) in 2025.
Earlier this year, Inspira introduced the INSPIRA Cardi-ART, a portable modular device, currently in development, to provide oxygen to the brain during cardiac arrest.
INSPIRA Cardi-ART is designed to support vital organ oxygenation during cardiac arrest to treat patients both in and outside of hospitals.
